CARLSBAD, California — In 2003, researchers asked 303 patients with systemic sclerosis (scleroderma) what bothered them most about their disease from an aesthetic standpoint: Orofacial features, such ...
Cyclophosphamide is widely used to treat severe manifestations of numerous autoimmune rheumatic diseases including systemic sclerosis. Based on recent data, immunological and inflammatory activation ...
Most people with scleroderma have autoantibodies. Several scleroderma-specific antibodies have been identified. These can help with diagnosis and give insight into the type of disease you may ...
NEW HAVEN, Conn. (WTNH) — June is Scleroderma Awareness Month, which draws attention to the autoimmune disease that leads to chronic hardening and tightening of connective tissues. Dr. Monique ...
Please provide your email address to receive an email when new articles are posted on . BLR-200 has yielded “promising” results in ongoing research. The therapy targets multiple drivers of scleroderma ...
Scleroderma on the face can cause symptoms that may affect your appearance, including the texture, discoloration, and elasticity of your skin. Medications, facial exercises, and dermatological ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Episodes of ...
Scleroderma is a rare autoimmune condition in which the regulation and deposition of collagen is impaired, causing inflammation and fibrosis (thickening and scarring of connective tissue) throughout ...
NEW HAVEN, Conn. (WTNH) — In today’s Health headlines, June is National Scleroderma Awareness Month. New research being conducted at Yale seeks to improve risk prediction. And, using AI to track the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback